On August 5, BrightSpring Health Services Inc. rose 5.12% in regular trading, trading at $63.58/share, with turnover of $182 million.

On the news front, the company reported Q2 adjusted earnings of $0.45 per share on July 31, beating the analyst consensus estimate of $0.40 by 12.5%, representing a 104.55% year-over-year increase from $0.22. Revenue came in at $3.87 billion, surpassing expectations of $3.66 billion, up 22.9% year-over-year. The company also raised its full-year revenue guidance to $15.10 billion to $15.43 billion, up from the prior range of $14.73 billion to $15.23 billion.

Additionally, Deutsche Bank raised its price target on the stock to $70 from $60 on August 3, maintaining a Buy rating. Multiple institutions have recently initiated or upgraded coverage, including Morgan Stanley raising its target to $80, Guggenheim initiating at $81, and UBS setting a target of $85. The analyst mean price target stands at $76.76, suggesting further upside from current levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)